What's the new normal for global oil?

Overview

This episode explores the economic ripple effects of global oil market volatility, rising trucking costs, and shifting trade policies. It also delves into the challenges of using AI in drug development and the impact of inconsistent solar energy policies on U.S. manufacturing.

Notable Quotes

- The new normal is essentially pricing in volatility, pricing in uncertainty. – Gernot Wagner, on the future of oil prices.

- Why am I going to pay somebody to have all the fun? – Brennan Waldron, on leaving his job to renovate a 100-year-old house.

- Faster discovery is enormously exciting, but finding a drug and proving that it works are still not the same thing. – Wendy Netter Epstein, on AI in drug development.

🛢️ The Volatile New Normal for Oil Markets

- U.S. oil prices surged past $100 per barrel, driven by disruptions in the Strait of Hormuz due to the U.S.-Iran conflict.

- Bhushan Bahri of S&P Global Energy predicts oil prices will remain between $80 and $100 per barrel through 2027, citing ongoing instability in the Middle East.

- Analysts like Samantha Gross argue that markets no longer trust optimistic proclamations about resolving the conflict, signaling a long-term shift in global oil dynamics.

🚛 Rising Trucking Costs and Inflation

- Diesel prices have skyrocketed, pushing trucking costs up by over 14% year-over-year, according to the Labor Department.

- A shortage of English-proficient drivers, exacerbated by stricter regulations, has reduced the number of trucks on the road, giving carriers more pricing power.

- Companies are forced to absorb higher costs or pass them to consumers, with some industries, like food manufacturing, struggling to maintain competitive pricing.

📦 Tariffs and Small Business Challenges

- Heather Bickford of Death by Audio shared frustrations over navigating the complex refund process for tariffs, with her business owed nearly $100,000.

- Despite tariff challenges, her company saw unexpected success with a new product launch, highlighting resilience in small business operations.

- Broader trade policies, including new tariffs on solar panel materials, aim to boost domestic manufacturing but create uncertainty for businesses reliant on global supply chains.

🔬 AI in Drug Development: Promise and Bottlenecks

- AI tools like Anthropic’s Claude Science are accelerating drug discovery by identifying biological targets and designing molecules faster than traditional methods.

- However, Wendy Netter Epstein warns of potential bottlenecks in FDA approval processes, which may not keep pace with AI-driven innovation.

- The FDA is exploring ways to modernize, such as reducing trial requirements for biosimilars, but challenges remain in balancing speed with safety.

🏠 Quitting the 9-to-5 for Personal Projects

- Construction manager Brennan Waldron left his job to renovate a 100-year-old house, citing a desire to take control of the project and enjoy the process.

- His story reflects a broader trend of individuals stepping away from traditional careers to pursue personal or entrepreneurial ventures.

- Waldron plans to re-enter the workforce but values the fulfillment of seeing a project through from start to finish.